Literature DB >> 8817448

Methimazole-induced cholestatic liver injury, mimicking sclerosing cholangitis.

G P Schwab1, G J Wetscher, W Vogl, E Redmond.   

Abstract

Cholestatic jaundice caused by imidazole derivates is a rare complication of antithyroid therapy. Only 20 such cases have been reported in the literature since the introduction of methimazole in 1949 and of carbimazole in 1953. We present a further case of methimazole-induced cholestatic liver injury, mimicking sclerosing cholangitis, where the etiology has been proven by a clear chronological relationship and the lack of other causative factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817448     DOI: 10.1007/bf00571690

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  17 in total

1.  Clinical experience with a new antithyroid drug: 2-carbethoxythio-1-methylglyoxaline.

Authors:  E C BARTELS
Journal:  J Clin Endocrinol Metab       Date:  1953-11       Impact factor: 5.958

2.  1-Methyl-2-mercaptoimidazole; an antithyroid compound highly active in man.

Authors:  M M STANLEY; E B ASTWOOD
Journal:  Endocrinology       Date:  1949-06       Impact factor: 4.736

3.  Death due to agranulocytosis induced by methimazole therapy.

Authors:  N W SPECHT; E J BOEHME
Journal:  J Am Med Assoc       Date:  1952-07-12

4.  Carbimazole-induced cholestatic hepatitis.

Authors:  C Ayensa; R Diaz de Otazu; J M Cia
Journal:  Arch Intern Med       Date:  1986-07

5.  Hepatitis from methimazole during adrenal steroid therapy for malignant exophthalmos.

Authors:  C E Becker; P Gorden; J Robbins
Journal:  JAMA       Date:  1968-11-18       Impact factor: 56.272

6.  Methimazole-induced jaundice.

Authors:  M G Fischer; H R Nayer; A Miller
Journal:  JAMA       Date:  1973-02-26       Impact factor: 56.272

7.  Jaundice due to carbimazole.

Authors:  M Lunzer; S N Huang; J Ginsburg; M Ahmed; S Sherlock
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

8.  Sclerosing cholangitis: broad spectrum of radiographic features.

Authors:  L Y Chen; H I Goldberg
Journal:  Gastrointest Radiol       Date:  1984

9.  Toxic hepatitis during treatment with methimazole (Tapazole). Report of a case with apparent recovery.

Authors:  J I TENNENBAUM; O H DRESKIN
Journal:  Ohio State Med J       Date:  1962-03

10.  A case of carbimazole-induced intrahepatic cholestasis. An immune-mediated reaction?

Authors:  H Blom; J Stolk; H B Schreuder; M von Blomberg-van der Flier
Journal:  Arch Intern Med       Date:  1985-08
View more
  7 in total

1.  Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity.

Authors:  Jianhua Li; Zahir Hussain; Junjie Zhu; Saifei Lei; Jie Lu; Xiaochao Ma
Journal:  Chem Res Toxicol       Date:  2021-11-17       Impact factor: 3.739

2.  A 40-year-old woman who developed jaundice during therapy for thyrotoxicosis.

Authors:  Chukwuma Ogbonna Ekpebegh; Naomi Sharlene Levitt
Journal:  PLoS Med       Date:  2006-01-31       Impact factor: 11.069

Review 3.  Factors affecting drug-induced liver injury: antithyroid drugs as instances.

Authors:  Reza Heidari; Hossein Niknahad; Akram Jamshidzadeh; Narges Abdoli
Journal:  Clin Mol Hepatol       Date:  2014-09-25

Review 4.  Secondary sclerosing cholangitis in critically ill patients: current perspectives.

Authors:  Hafsteinn O Gudnason; Einar S Björnsson
Journal:  Clin Exp Gastroenterol       Date:  2017-06-23

Review 5.  Drug-induced cholestasis.

Authors:  Vinay Sundaram; Einar S Björnsson
Journal:  Hepatol Commun       Date:  2017-09-11

6.  Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use.

Authors:  Scott A Rivkees; Donald R Mattison
Journal:  Int J Pediatr Endocrinol       Date:  2009-04-21

7.  Long-Term Outcomes After Drug-Induced Liver Injury.

Authors:  Paul H Hayashi; Einar S Bjornsson
Journal:  Curr Hepatol Rep       Date:  2018-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.